News

Canalevia-CA1, a canine-specific formulation of crofelemer, Jaguar's novel, oral plant-based drug sustainably harvested from the Croton lechleri tree, is available from multiple leading veterinary ...
A watchdog has cracked down on a host of weight-loss jab providers for advertising the prescription-only medications to the ...
FDA's secret drug exemptions let tainted medications reach U.S. patients, risking lives while sidelining safety reports and inspector warnings.
A series of adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting ...
Optum Rx has added more than 60 additional drugs to a list for which it is eliminating reauthorization requirements, ...
A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...
It is illegal to advertise prescription-only weight loss drugs and Ms Collins' was one of nine adverts banned in a crackdown ...
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.
The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...
FDA assigns PDUFA target action date of January 31, 2026 WARREN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a ...